These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22229580)

  • 1. GRK2 at the control shaft of cellular metabolism.
    Ciccarelli M; Cipolletta E; Iaccarino G
    Curr Pharm Des; 2012; 18(2):121-7. PubMed ID: 22229580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia.
    Ciccarelli M; Chuprun JK; Rengo G; Gao E; Wei Z; Peroutka RJ; Gold JI; Gumpert A; Chen M; Otis NJ; Dorn GW; Trimarco B; Iaccarino G; Koch WJ
    Circulation; 2011 May; 123(18):1953-62. PubMed ID: 21518983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The G protein coupled receptor kinase 2 plays an essential role in beta-adrenergic receptor-induced insulin resistance.
    Cipolletta E; Campanile A; Santulli G; Sanzari E; Leosco D; Campiglia P; Trimarco B; Iaccarino G
    Cardiovasc Res; 2009 Dec; 84(3):407-15. PubMed ID: 19620130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G protein-coupled receptor kinase 2 ablation in cardiac myocytes before or after myocardial infarction prevents heart failure.
    Raake PW; Vinge LE; Gao E; Boucher M; Rengo G; Chen X; DeGeorge BR; Matkovich S; Houser SR; Most P; Eckhart AD; Dorn GW; Koch WJ
    Circ Res; 2008 Aug; 103(4):413-22. PubMed ID: 18635825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tonic inhibition by G protein-coupled receptor kinase 2 of Akt/endothelial nitric-oxide synthase signaling in human vascular endothelial cells under conditions of hyperglycemia with high insulin levels.
    Taguchi K; Sakata K; Ohashi W; Imaizumi T; Imura J; Hattori Y
    J Pharmacol Exp Ther; 2014 May; 349(2):199-208. PubMed ID: 24570070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GRK2 as a therapeutic target for heart failure.
    Cannavo A; Komici K; Bencivenga L; D'amico ML; Gambino G; Liccardo D; Ferrara N; Rengo G
    Expert Opin Ther Targets; 2018 Jan; 22(1):75-83. PubMed ID: 29166798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart.
    Pfleger J; Gross P; Johnson J; Carter RL; Gao E; Tilley DG; Houser SR; Koch WJ
    J Mol Cell Cardiol; 2018 Oct; 123():108-117. PubMed ID: 30171848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myocardial GRK2 Reduces Fatty Acid Metabolism and β-Adrenergic Receptor-Mediated Mitochondrial Responses.
    Zhai R; Varner EL; Rao A; Karhadkar S; Di Carlo A; Snyder NW; Sato PY
    Int J Mol Sci; 2022 Mar; 23(5):. PubMed ID: 35269919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin induces IRS2-dependent and GRK2-mediated β2AR internalization to attenuate βAR signaling in cardiomyocytes.
    Fu Q; Xu B; Parikh D; Cervantes D; Xiang YK
    Cell Signal; 2015 Mar; 27(3):707-15. PubMed ID: 25460042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G protein-coupled receptor kinase 2 plays a relevant role in insulin resistance and obesity.
    Garcia-Guerra L; Nieto-Vazquez I; Vila-Bedmar R; Jurado-Pueyo M; Zalba G; Díez J; Murga C; Fernández-Veledo S; Mayor F; Lorenzo M
    Diabetes; 2010 Oct; 59(10):2407-17. PubMed ID: 20627936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of G protein-coupled receptor kinase 2 levels enhances cardiac insulin sensitivity and switches on cardioprotective gene expression patterns.
    Lucas E; Jurado-Pueyo M; Fortuño MA; Fernández-Veledo S; Vila-Bedmar R; Jiménez-Borreguero LJ; Lazcano JJ; Gao E; Gómez-Ambrosi J; Frühbeck G; Koch WJ; Díez J; Mayor F; Murga C
    Biochim Biophys Acta; 2014 Dec; 1842(12 Pt A):2448-56. PubMed ID: 25239306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4.
    Theccanat T; Philip JL; Razzaque AM; Ludmer N; Li J; Xu X; Akhter SA
    Cell Signal; 2016 Mar; 28(3):190-203. PubMed ID: 26631573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restricting mitochondrial GRK2 post-ischemia confers cardioprotection by reducing myocyte death and maintaining glucose oxidation.
    Sato PY; Chuprun JK; Grisanti LA; Woodall MC; Brown BR; Roy R; Traynham CJ; Ibetti J; Lucchese AM; Yuan A; Drosatos K; Tilley DG; Gao E; Koch WJ
    Sci Signal; 2018 Dec; 11(560):. PubMed ID: 30538174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of diet-induced obesity and insulin resistance by inducible genetic ablation of GRK2.
    Vila-Bedmar R; Cruces-Sande M; Lucas E; Willemen HL; Heijnen CJ; Kavelaars A; Mayor F; Murga C
    Sci Signal; 2015 Jul; 8(386):ra73. PubMed ID: 26198359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism.
    Woodall MC; Ciccarelli M; Woodall BP; Koch WJ
    Circ Res; 2014 May; 114(10):1661-70. PubMed ID: 24812353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis.
    Mayor F; Cruces-Sande M; Arcones AC; Vila-Bedmar R; Briones AM; Salaices M; Murga C
    Cell Signal; 2018 Jan; 41():25-32. PubMed ID: 28389415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. G-Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitors: Current Trends and Future Perspectives.
    Guccione M; Ettari R; Taliani S; Da Settimo F; Zappalà M; Grasso S
    J Med Chem; 2016 Oct; 59(20):9277-9294. PubMed ID: 27362616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GRK2 as negative modulator of NO bioavailability: Implications for cardiovascular disease.
    Cannavo A; Koch WJ
    Cell Signal; 2018 Jan; 41():33-40. PubMed ID: 28077324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating GRK2 and NFkappaB in the Pathophysiology of Cardiac Hypertrophy.
    Sorriento D; Santulli G; Franco A; Cipolletta E; Napolitano L; Gambardella J; Gomez-Monterrey I; Campiglia P; Trimarco B; Iaccarino G; Ciccarelli M
    J Cardiovasc Transl Res; 2015 Nov; 8(8):493-502. PubMed ID: 26224342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.